Search

Search results

548 results found

One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients with Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study

Sun, Jennifer, Raj Maturi, David Boyer, John Wells, Victor Gonzalez, Robert Tansley, Helen Hernandez, Andreas Maetzel, Edward Feener, and Lloyd Paul Aiello. 2019. “One-Time Intravitreal Injection of KVD001, a Plasma Kallikrein Inhibitor, in Patients With Central-Involved Diabetic Macular Edema and Reduced Vision: An Open-Label Phase 1B Study”. Ophthalmol Retina 3 (12): 1107-9.